REYON Pharmaceutical Co., Ltd. (KRX:102460)

REYON Pharmaceutical Revenue

REYON Pharmaceutical had revenue of 35.85B KRW in the quarter ending June 30, 2026, a decrease of -4.90%. This brings the company's total for the last twelve months to 143.37B, down -4.45% year-over-year. In the year 2025, REYON Pharmaceutical had annual revenue of 145.93B, down -1.60%. That makes REYON Pharmaceutical the 22,036th largest company in the world by revenue and 1,227th in South Korea.

• Revenue (ttm): 143.37B
• Revenue Growth: -4.45%
• P/S Ratio: 1.25
• Revenue / Employee: 311.01M
• Employees: 461
• Market Cap: 178.64B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Republic of Korea 144.31B 98.9%
• Japan 949.60M 0.7%
• Vietnam 433.28M 0.3%
• Mongolia 88.15M 0.1%
• Chile 55.91M 0.0%
• Other 52.30M 0.0%
• Thailand 34.60M 0.0%

Fiscal year ended Dec 31, 2025 See the full REYON Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	145.93B	-2.37B	-1.60%
Dec 31, 2024	148.30B	-2.77B	-1.83%
Dec 31, 2023	151.07B	-2.97B	-1.93%
Dec 31, 2022	154.04B	11.24B	7.87%
Dec 31, 2021	142.80B	12.77B	9.82%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error